Search
Thromboembolic disorders
go.drugbank.com/conditions/DBCOND0096925Drugs: PicotamideSynonyms: Embolism and thrombosis of unspecified siteAcriflavine
go.drugbank.com/drugs/DB13373InvestigationalCategories: Indicators and Reagents, Compounds used in a research, industrial, or household settingProducts: DERMOPLEX BURN AID CREAMInborn Errors of Bile Acid Synthesis
go.drugbank.com/conditions/DBCOND0046673Drugs: Cholic AcidSynonyms: Inborn error in primary bile acid synthesisLambert Eaton Myasthenic Syndrome (LEMS)
go.drugbank.com/conditions/DBCOND0053084Drugs: AmifampridineSynonyms: Lambert-Eaton syndrome in neoplastic diseaseVosoritide
go.drugbank.com/drugs/DB11928ApprovedInvestigationalAchondroplasia is an autosomal dominant genetic disease and the most common cause of dwarfism in humans. … [L39229] It was approved for use under the brand name Voxzogo (BioMarin Pharmaceutical Inc.) in the EU in August 2021 and the US in November 2021,[L39245,L39241] becoming the first pharmacological intervention
Categories: Amino Acids, Peptides, and Proteins, Drugs Affecting Bone Structure and MineralizationFlosequinan
go.drugbank.com/drugs/DB13228ApprovedWithdrawnFlosequinan was approved in the USA and the UK for a year prior to being withdrawn from the market due to increased mortality in chronic heart failure patients, found in drug trials.[A174979,L43942]
Categories: Vasodilators Used in Cardiac DiseasesRibavirin
go.drugbank.com/drugs/DB00811ApprovedInvestigationalIn HCV genotye 1/2/3/4/5/6 patients, ribavirin can be used in combination therapy involving [DB09102] and [DB08934], Eplusa ([DB08934], [DB11613]), Harvoni ([DB08934], [DB09027]), [DB06290] and [DB08934 … Ribavirin is added to decrease relapse rates by accelerating viral clearance early in the treatment course [A19645].
Mixtures: Rebetron Ready To Use Solution (albumin(human)free) (6000000 Iu/ml and 200mg Capsules), Rebetron Solution (albumin (human) Free) (18 Miu Multi-dose Pen / 200mg Capsules)Categories: Nucleosides and Nucleotides, Nucleic Acids, Nucleotides, and NucleosidesTriamterene
go.drugbank.com/drugs/DB00384ApprovedTriamterene is a weak antagonist of folic acid, and a photosensitizing drug.[L6163] Triamterene was approved by the Food and Drug Administration in the U.S. in 1964. … It works by promoting the excretion of sodium ions and water while decreasing the potassium excretion in the distal part of the nephron in the kidneys by working on the lumenal side.
Mixtures: Riva-zide 50/25mg Tablets, TRI THIAZID STADA 50/25MGCategories: Decreased Renal K+ ExcretionFinafloxacin
go.drugbank.com/drugs/DB09047ApprovedWithdrawnFinafloxacin is marketed by Novartis under the brand Xtoro™, and was approved by the FDA in December 2014. … Finafloxacin is a fluoroquinolone antibiotic indicated in the treatment of acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.
Categories: Topoisomerase II InhibitorsCamizestrant
go.drugbank.com/drugs/DB19218ApprovedInvestigational[L64094,L64107] In pre- or peri-menopausal women and in men, camizestrant plus a CDK4/6 inhibitor is combined with an LHRH agonist or antagonist. … [L64094,L64107] Patients are selected for treatment on the basis of an *ESR1* mutation detected by circulating tumor DNA testing during first-line endocrine therapy, before radiographic disease progression
Synonyms: 3-pyridinamine, n-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6s,8r)-6,7,8,9-tetrahydro-8-methyl-7-(2,2,2-trifluoroethyl)-3h-pyrazolo(4,3-f)isoquinolin-6-yl)-, N-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6s,8r)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3h-pyrazolo(4,3-f)isoquinolin-6-yl)-3-pyridinamineCategories: Antineoplastic and Immunomodulating Agents, Hormone Antagonists and Related Agents